LINKAGE GLOBAL INC (LGCB) Fundamental Analysis & Valuation

NASDAQ:LGCB • KYG5500B1288

Current stock price

1.49 USD
+0.05 (+3.47%)
Last:

This LGCB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. LGCB Profitability Analysis

1.1 Basic Checks

  • In the past year LGCB has reported negative net income.
  • In the past year LGCB has reported a negative cash flow from operations.
LGCB Yearly Net Income VS EBIT VS OCF VS FCFLGCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M -2M -3M

1.2 Ratios

  • The Return On Assets of LGCB (-3.46%) is worse than 66.67% of its industry peers.
  • LGCB has a Return On Equity of -6.25%. This is in the lower half of the industry: LGCB underperforms 63.33% of its industry peers.
Industry RankSector Rank
ROA -3.46%
ROE -6.25%
ROIC N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LGCB Yearly ROA, ROE, ROICLGCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 -10 20 30

1.3 Margins

  • Looking at the Gross Margin, with a value of 40.49%, LGCB is doing worse than 60.00% of the companies in the same industry.
  • LGCB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LGCB Yearly Profit, Operating, Gross MarginsLGCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 10 20 30 40

6

2. LGCB Health Analysis

2.1 Basic Checks

  • LGCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LGCB has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, LGCB has an improved debt to assets ratio.
LGCB Yearly Shares OutstandingLGCB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 500K 1M 1.5M 2M
LGCB Yearly Total Debt VS Total AssetsLGCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • LGCB has an Altman-Z score of 3.53. This indicates that LGCB is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.53, LGCB is in the better half of the industry, outperforming 76.67% of the companies in the same industry.
  • LGCB has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • LGCB has a Debt to Equity ratio of 0.26. This is in the better half of the industry: LGCB outperforms 63.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 3.53
ROIC/WACCN/A
WACC6.76%
LGCB Yearly LT Debt VS Equity VS FCFLGCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

  • A Current Ratio of 2.73 indicates that LGCB has no problem at all paying its short term obligations.
  • LGCB has a Current ratio of 2.73. This is amongst the best in the industry. LGCB outperforms 96.67% of its industry peers.
  • A Quick Ratio of 2.71 indicates that LGCB has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.71, LGCB belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.71
LGCB Yearly Current Assets VS Current LiabilitesLGCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M 8M 10M

0

3. LGCB Growth Analysis

3.1 Past

  • LGCB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.43%, which is quite impressive.
  • LGCB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.19%.
EPS 1Y (TTM)36.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.38%
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGCB Yearly Revenue VS EstimatesLGCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M 20M

0

4. LGCB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LGCB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LGCB Price Earnings VS Forward Price EarningsLGCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LGCB is valued a bit more expensive than the industry average as 70.00% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1616.35
LGCB Per share dataLGCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. LGCB Dividend Analysis

5.1 Amount

  • No dividends for LGCB!.
Industry RankSector Rank
Dividend Yield 0%

LGCB Fundamentals: All Metrics, Ratios and Statistics

LINKAGE GLOBAL INC

NASDAQ:LGCB (3/24/2026, 2:01:26 PM)

1.49

+0.05 (+3.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.2%
Inst Owner ChangeN/A
Ins Owners41.3%
Ins Owner Change0%
Market Cap17.98M
Revenue(TTM)10.29M
Net Income(TTM)-439.30K
AnalystsN/A
Price TargetN/A
Short Float %0.11%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.75
P/FCF N/A
P/OCF N/A
P/B 2.56
P/tB 2.56
EV/EBITDA 1616.35
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.85
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -6.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.49%
FCFM N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)4.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 178.38
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.71
Altman-Z 3.53
F-Score4
WACC6.76%
ROIC/WACCN/A
Cap/Depr(3y)201.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-56.87%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y89.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.89%
OCF growth 3YN/A
OCF growth 5YN/A

LINKAGE GLOBAL INC / LGCB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LINKAGE GLOBAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to LGCB.


What is the valuation status for LGCB stock?

ChartMill assigns a valuation rating of 0 / 10 to LINKAGE GLOBAL INC (LGCB). This can be considered as Overvalued.


Can you provide the profitability details for LINKAGE GLOBAL INC?

LINKAGE GLOBAL INC (LGCB) has a profitability rating of 0 / 10.


What is the financial health of LINKAGE GLOBAL INC (LGCB) stock?

The financial health rating of LINKAGE GLOBAL INC (LGCB) is 6 / 10.